Covaxin Maker Seeks Approval In US For Children Under 18 Years

Bharat Biotech's partner Ocugen on November 6, asked the US Food and Drug Administration (FDA) for the emergency use authorisation of Covaxin for children under 18 years. Earlier the vaccine was granted approval by the World Health Organisation (WHO) for its Emergency Use Listing (EUL). "We are pleased to announce our EUA filing to the US-FDA through our partners-Ocugen," twitted Dr Raches Ella, Bharat Biotech's clinical lead.